TRUALT TruAlt Bioenergy Q3 FY26 results (Oct–Dec 2025) and concall
TruAlt Bioenergy reported robust growth in Q3 FY26, driven by increased ethanol plant utilization and strong performance in the CBG segment. The company is aggressively expanding its CBG and Sustainable Aviation Fuel (SAF) verticals, with significant capex plans and strategic partnerships. Despite a slight dip in 9-month PBT due to fixed cost absorption during partial plant shutdowns, management is confident in future revenue and margin expansion, supported by policy tailwinds and new project commissioning.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 71.8%, net profit down 8.0% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|
| Revenue | 415 | 907 | 304 | 115 | 713 +72% |
| EBITDA | 125 | 154 | 42 | -5 | 134 +7% |
| Net profit | 75 | 112 | 5 | -38 | 69 −8% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
